Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1Endocrine 1

Conditions

Leukemia 16Carcinoma, Renal Cell 15Leukemia, Myeloid, Chronic-Phase 13Kidney Neoplasms 12Leukemia, Myelogenous, Chronic, BCR-ABL Positive 10Melanoma 8Multiple Myeloma 7Pancreatic Neoplasms 6Lymphoma 6Neoplasms, Plasma Cell 5Lymphoma, Follicular 5Neoplasms 4Lymphoma, Mantle-Cell 4Leukemia, Myeloid, Acute 4Leukemia, Myeloid, Accelerated Phase 4Carcinoma, Hepatocellular 4Waldenstrom Macroglobulinemia 3Urinary Bladder Neoplasms 3Lymphoma, Non-Hodgkin 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Large B-Cell, Diffuse 3Leukemia, Lymphocytic, Chronic, B-Cell 3Stomach Neoplasms 2Skin Neoplasms 2Recurrence 2Polycythemia Vera 2Lymphoma, B-Cell, Marginal Zone 2Esophageal Squamous Cell Carcinoma 2Esophageal Neoplasms 2Carcinoma, Non-Small-Cell Lung 2

Interventions

Etoposide 79Carboplatin 67Cisplatin 58durvalumab 29Irinotecan 29Radiotherapy 27atezolizumab 23Topotecan 21anlotinib 19Nivolumab 15Drug Therapy 15Radiosurgery 14Gemcitabine 13apatinib 12Paclitaxel 12toripalimab 10Platinum 10Docetaxel 10tislelizumab 9Temozolomide 9PM 01183 8pembrolizumab 7olaparib 7Magnetic Resonance Spectroscopy 7Ipilimumab 7Bevacizumab 7Albumin-Bound Paclitaxel 7irinotecan sucrosofate 6Counseling 6sintilimab 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Small Cell Lung Carcinoma × Interferon-alpha × Clear all
NCT00178698 2011-03-03

FR-WB-TT/che

The University of Texas Health Science Center, Houston

Phase 2 Unknown
36 enrolled
EndocrineGastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Stomach Neoplasms, Carcinoma, Neuroendocrine, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡